The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
about
DNA methylation characteristics of primary melanomas with distinct biological behaviour.Melanoma: clinical features and genomic insights.PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.The CCND1 G870A polymorphism and susceptibility to bladder cancer.Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.Chromosome 10, frequently lost in human melanoma, encodes multiple tumor-suppressive functions.Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma.DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation.TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor.The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.The significant association of CCND1 genotypes with colorectal cancer in Taiwan.Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas.Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.
P2860
Q33617915-64426C9F-1B73-46AE-9FFF-89F1A4820E4FQ34083191-417B957C-332B-448F-A245-B95B61497628Q34346022-7BDDBCA5-A901-44E5-861A-FA5224347931Q34871503-5125B559-DDD1-461A-83A1-03DA0BC3174BQ36019187-C06688D4-55B2-4ADA-A32C-49C5078A2FFCQ37677180-A580DFA0-ECD8-4DA0-B28E-CD5CC4B87B42Q38089631-B6FD5B70-CBF6-4CD9-A67C-C7198F114906Q38120311-75A49B4C-B045-4802-9FCA-EB8CE13FCB0FQ39003350-951B9D2F-004C-435F-949C-F29F2BF69B45Q39021096-6B2234CA-D073-4C97-AC5C-A87798C4781EQ47156987-0B97AE7D-5AF3-4DF3-92D4-914B5AD74B8CQ47391313-AAAB8B13-DB72-4591-A5A9-25B899E25F84Q47400999-B1D5D553-7249-4305-8828-67B357A48756Q51777015-9E202027-41A0-4622-A27D-F959DE473C7CQ52956185-3EA28166-4FA8-4AEE-8670-F00D97991ED5Q53059959-6D7C5260-8899-4E8C-9447-A521E9C17FBFQ53089129-1411CFA0-86A4-4BD5-A127-B3473C758F05
P2860
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
@en
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
@nl
type
label
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
@en
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
@nl
prefLabel
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
@en
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
@nl
P2093
P2860
P1433
P1476
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
@en
P2093
Adrienn Orosz
Gabriella Emri
Laura Vízkeleti
Margit Balázs
Róza Ádány
Szilvia Ecsedi
Tímea Kiss
Viktória Koroknai
Viktória Lázár
Zsuzsa Rákosy
P2860
P2888
P304
P356
10.1007/S13277-012-0480-6
P577
2012-09-23T00:00:00Z